Table 6 Overview of the analyzed subjects from the ADNI cohort, including age and clinical information at baseline.
ALL | HC | sMCI | pMCI | AD | |
|---|---|---|---|---|---|
# of subjects/images at baseline | 1069 | 404 | 166 | 177 | 322 |
gender (# male/# female) | 581/488 | 202/202 | 98/68 | 104/73 | 177/145 |
years of age (median [min; max]) | 74.6 [48.1; 91.4] | 74.2 [59.8; 89.6] | 74.4 [55.9; 91.4] | 74.3 [48.1; 88.3] | 75.8 [55.1; 91.4] |
ApoE4 (# 0/# 1/# 2)† | 547/407/113 | 293/101/9 | 93/60/13 | 57/91/29 | 104/155/62 |
MMSE (median [min; max]) | 27 [18; 30] | 29 [24; 30] | 28 [24; 30] | 26 [23; 30] | 23 [18; 27] |
FAQ (median [min; max])‡ | 1 [0; 30] | 0 [0; 6] | 1 [0; 21] | 5 [0; 21] | 13 [0; 30] |
CDRSB (median [min; max]) | 1.5 [0; 10] | 0 [0; 1] | 1.5 [0.5; 4] | 2 [0.5; 5] | 4.5 [1; 10] |
FieldStrength (1.5T/3T) | 653/416 | 223/181 | 112/54 | 129/48 | 189/133 |
# of subjects/images at month 12 | 802 | 195 | 149 | 168 | 290 |
# of subjects/images at month 24 | 532 | 168 | 107 | 140 | 117 |
